Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
OraSure Technologies received FDA Emergency Use Authorization for its OraQuick Ebola Rapid Antigen Test, which is designed to detect viral antigens in fingerstick and venous whole blood from patients presenting with signs and symptoms of Ebola infection in conjunction with epidemiological risk factors.
Bio SB announced a new line of rabbit monoclonal antibodies, SOX-10–RMab, for immunohistochemistry with extensive protein immunogenicity analysis of targeted epitopes, high sensitivity specificity, and low background noise.
LabRight Certification, from Vacava, is a tool for lab professionals that automates lab certification and accreditation management and aims to increase efficiency and lower operating costs by eliminating paperwork.
MedCompGx, a division of MedComp Sciences, announced the installation and implementation of UniConnect’s Precision MDx laboratory information management system for its new genetic testing lab. The system provides automation of all processes while integrating with multiple systems under one umbrella.
Sysmex announced its Beyond a Better Box product and services model to deliver a comprehensive and intuitive ecosystem that aims to add value to laboratory hematology operations through next-generation diagnostics, advanced tools and technologies, process optimization, and harmonized support known as BeyondCare.
New products featured by Streck this year included CD-Chex CD103 Plus, a flow cytometry control. It includes CD103, CD30, CD38, CD56, CD138, and cytoplasmic lambda in a single control and provides reference values for CD38. The control includes rare leukemia and lymphoma CD markers that are absent in normal whole blood.
Siemens Healthcare Diagnostics revealed its latest IVD solutions, including the Advia Centaur XPT Immunoassay System. Recently FDA-cleared, this high-throughput analyzer is designed to provide continuous operation and seamless connectivity, including to Aptio Automation. The XPT is not available in the U.S.
The family of Phadia instruments from Thermo Fisher Scientific now includes the Phadia 2500E Laboratory System for laboratories meeting high demands. Phadia Laboratory Systems are fully automated instruments for running assays that detect and quantitatively determine clinically relevant antibodies in the blood.
The BBI Group developed, in collaboration with the Defence Science and Technology Laboratory, a rapid test for Ebola that is in the process of being verified to allow EUA submission. Using lateral flow technology, BBI’s assay will make testing simpler and quicker than assays that require technical infrastructure.
Cepheid unveiled the GeneXpert Omni, a portable molecular diagnostics system enabling access to accurate, fast, and potentially life-saving diagnosis of tuberculosis, HIV, and Ebola in even the most remote areas of the world.
